Predict your next investment

Corporation
HEALTHCARE | Medical Devices & Equipment
bioclinica.com

See what CB Insights has to offer

Stage

Divestiture

Investors Count

5

Deal Terms

1

Portfolio Exits

1

BioClinica Funding, BioClinica Valuation & BioClinica Revenue

5 Fundings

BioClinica's latest funding round was a Merger for on December 10, 2020.

BioClinica's valuation in January 2013 was $123M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/10/2020

Merger

9

10/8/2018

Acquired

10

1/30/2013

Take Private

$123M

$0.00B

((9.99x))

FY 1234

10

1/1/1990

IPO

0

Other Investors

0

Date

12/10/2020

10/8/2018

1/30/2013

1/1/1990

Round

Merger

Acquired

Take Private

IPO

Other Investors

Amount

Investors

Valuation

$123M

Revenue

$0.00B

((9.99x))

FY 1234

Sources

9

10

10

0

0

BioClinica Deal Terms

1 Deal Term

BioClinica's deal structure is available for 1 funding round, including their Take Private from January 30, 2013.

Round

Take Private

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

$99M

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Take Private

$99M

$99M

$99M

$99M

BioClinica Investors

5 Investors

BioClinica has 5 investors. Clario invested in BioClinica's Merger funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/10/2020

12/10/2020

1
Merger

Corporation

Pennsylvania

00/00/0000

00/00/0000

H. Hemo

Subscribe to see more

Corporation

00/00/0000

00/00/0000

JLL Partners

Subscribe to see more

Private Equity

New York

00/00/0000

00/00/0000

Water Street Healthcare Partners

Subscribe to see more

Private Equity

Illinois

SV Health Investors

Subscribe to see more

Venture Capital

Massachusetts

First funding

12/10/2020

00/00/0000

00/00/0000

00/00/0000

Last Funding

12/10/2020

00/00/0000

00/00/0000

00/00/0000

Investor

H. Hemo

JLL Partners

Water Street Healthcare Partners

SV Health Investors

Rounds

1
Merger

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporation

Corporation

Private Equity

Private Equity

Venture Capital

Location

Pennsylvania

New York

Illinois

Massachusetts

BioClinica Acquisitions

9 Acquisitions

BioClinica acquired 9 companies. Their latest acquisition was Saliency on January 06, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/6/2021

Other

$99M

Acquired

3

11/6/2017

Subscribe to see more

$99M

Subscribe to see more

10

7/25/2016

Subscribe to see more

$99M

Subscribe to see more

10

1/19/2016

Series C

Subscribe to see more

$99M

$99M

Subscribe to see more

10

9/21/2015

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/6/2021

11/6/2017

7/25/2016

1/19/2016

9/21/2015

Investment Stage

Other

Series C

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$99M

Note

Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

10

10

10

10

BioClinica Portfolio Exits

1 Portfolio Exit

BioClinica has 1 portfolio exit. Their latest portfolio exit was BioClinica - Global Site Business on September 05, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/5/2019

Divestiture

5

Date

9/5/2019

Exit

Divestiture

Companies

Valuation

Acquirer

Sources

5

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.